TrialFuture oncology (London, England)2019

JAVELIN Head and Neck 100: a Phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer.

Yao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.